THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Life Sciences: Biotech

AIDS activists remain wary of drug maker

Distrust comes as Serono pushes new use for treatment

By Ross Kerber
Globe Staff / November 14, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

As the calamari arrived at their table in a restaurant overlooking San Francisco Bay, Hisham Samra wrote the number ''50" on a piece of paper and slid it to Jeff Getty, a member of the AIDS activist group Act Up. (Full article: 958 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass